These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 25426290)
1. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Seto CT; Jeraldo P; Orenstein R; Chia N; DiBaise JK Microbiome; 2014; 2():42. PubMed ID: 25426290 [TBL] [Abstract][Full Text] [Related]
2. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study. Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620 [TBL] [Abstract][Full Text] [Related]
3. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization. Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005 [TBL] [Abstract][Full Text] [Related]
4. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection. McDonald EG; Milligan J; Frenette C; Lee TC JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198 [TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection. Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023 [TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection. Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors. Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470 [TBL] [Abstract][Full Text] [Related]
8. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model. Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246 [TBL] [Abstract][Full Text] [Related]
9. Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection. Džunková M; Moya A; Vázquez-Castellanos JF; Artacho A; Chen X; Kelly C; D'Auria G mSphere; 2016; 1(3):. PubMed ID: 27303742 [TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Barletta JF; Sclar DA Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023 [TBL] [Abstract][Full Text] [Related]
11. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. Takagi T; Naito Y; Inoue R; Kashiwagi S; Uchiyama K; Mizushima K; Tsuchiya S; Okayama T; Dohi O; Yoshida N; Kamada K; Ishikawa T; Handa O; Konishi H; Okuda K; Tsujimoto Y; Ohnogi H; Itoh Y J Clin Biochem Nutr; 2018 Jan; 62(1):100-105. PubMed ID: 29371761 [TBL] [Abstract][Full Text] [Related]
12. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794 [TBL] [Abstract][Full Text] [Related]
18. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Stevens V; Dumyati G; Brown J; Wijngaarden E Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992 [TBL] [Abstract][Full Text] [Related]
19. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. Cao F; Chen CX; Wang M; Liao HR; Wang MX; Hua SZ; Huang B; Xiong Y; Zhang JY; Xu YL J Hosp Infect; 2018 Jan; 98(1):4-13. PubMed ID: 28842261 [TBL] [Abstract][Full Text] [Related]